| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 6 |
| 1 | RITONAVIR | 6 |
| 2 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 |
| 3 | SOMATROPIN | 2 |
| 4 | DARUNAVIR 600 MG | 1 |
| 5 | DARUNAVIR 800 MG | 1 |
| 6 | DOBUTAMINE HYDROCHLORIDE | 1 |
| 7 | GALSULFASE | 1 |
| 8 | LAMOTRIGINE | 1 |
| 9 | RITONAVIR 100 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 1 | DARUNAVIR | 6 | 0.0004 |
| 2 | GALSULFASE | 1 | 0.0003 |
| 3 | DARUNAVIR 600 MG | 1 | 0.0002 |
| 4 | RITONAVIR 100 MG | 1 | 0.0001 |
| 5 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0000 |
| 6 | SOMATROPIN | 2 | 0.0000 |
| 7 | LAMOTRIGINE | 1 | 0.0000 |
| 8 | RITUXIMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Mood Stabilizer [EPC] | 1 | 0.0000 |
| 6 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |